Virtu Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,808
| Closed | -$343K | – | 1252 |
|
|
2023
Q2 | $343K | Buy |
+1,808
| New | +$343K | 0.03% | 553 |
|
|
2022
Q2 | – | Sell |
-3,862
| Closed | -$631K | – | 1540 |
|
|
2022
Q1 | $631K | Sell |
3,862
-4,445
| -54% | -$726K | 0.05% | 327 |
|
|
2021
Q4 | $1.41M | Buy |
+8,307
| New | +$1.41M | 0.14% | 135 |
|
|
2021
Q3 | – | Sell |
-3,092
| Closed | -$524K | – | 1457 |
|
|
2021
Q2 | $524K | Buy |
+3,092
| New | +$524K | 0.05% | 452 |
|
|
2019
Q4 | $1.28M | Buy |
+11,147
| New | +$1.28M | 0.12% | 177 |
|
|
2019
Q2 | – | Sell |
-3,720
| Closed | -$348K | – | 1414 |
|
|
2019
Q1 | $348K | Buy |
+3,720
| New | +$348K | 0.02% | 707 |
|
|
2018
Q4 | – | Sell |
-7,884
| Closed | -$690K | – | 1512 |
|
|
2018
Q3 | $690K | Buy |
7,884
+2,817
| +56% | +$247K | 0.04% | 460 |
|
|
2018
Q2 | $499K | Sell |
5,067
-4,405
| -47% | -$434K | 0.03% | 791 |
|
|
2018
Q1 | $1.13M | Buy |
+9,472
| New | +$1.13M | 0.06% | 318 |
|
|
2017
Q4 | – | Sell |
-2,435
| Closed | -$286K | – | 2324 |
|
|
2017
Q3 | $286K | Buy |
+2,435
| New | +$286K | 0.01% | 1434 |
|
|
2015
Q3 | – | Sell |
-3,837
| Closed | -$460K | – | 299 |
|
|
2015
Q2 | $460K | Buy |
+3,837
| New | +$460K | 0.04% | 211 |
|